Literature DB >> 24938356

Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway.

Yimin Lu1, Changjiang Wei, Zhaoqing Xi.   

Abstract

Curcumin, a naturally occurring phenolic compound, has a diversity of antitumor activities. It has been previously demonstrated that curcumin can inhibit the invasion and metastasis of tumors through activation of the tumor suppressor DnaJ-like heat shock protein 40 (HLJ1). However, the specific roles and mechanisms of curcumin in regulating the malignant behaviors of non-small cell lung cancer (NSCLC) cells still remain unclear. In this study, we found that curcumin could inhibit the proliferation and invasion of NSCLC cells and induce G0/G1 phase arrest. Metastasis-associated protein 1 (MTA1) overexpression has been detected in a wide variety of aggressive tumors and plays an important role on cell invasion and metastasis. Our results showed that curcumin could effectively inhibit the MTA1 expression of NSCLC cells. Further research on the subsequent mechanism showed that curcumin inhibited the proliferation and invasion of NSCLC cells through MTA1-mediated inactivation of Wnt/β-catenin pathway. Wnt/β-catenin signaling was reported to play a critical cooperative role on promoting lung tumorigenesis. Thus, these investigations provided novel insights into the mechanisms of curcumin on inhibition of NSCLC cell growth and invasion and showed potential therapeutic strategies for NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938356     DOI: 10.1007/s11626-014-9779-5

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  34 in total

1.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

Authors:  J Brognard; A S Clark; Y Ni; P A Dennis
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

Review 3.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

4.  Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.

Authors:  Shin-Hwar Wu; Liang-Wen Hang; Jai-Sing Yang; Hung-Yi Chen; Hui-Yi Lin; Jo-Hua Chiang; Chi-Cheng Lu; Jiun-Long Yang; Tung-Yuan Lai; Yang-Ching Ko; Jing-Gung Chung
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

5.  Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.

Authors:  Yonggang Li; Jingru Zhang; Daoxin Ma; Lei Zhang; Meng Si; Han Yin; Jianmin Li
Journal:  FEBS J       Date:  2012-05-21       Impact factor: 5.542

6.  Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation.

Authors:  Varisa Pongrakhananon; Ubonthip Nimmannit; Sudjit Luanpitpong; Yon Rojanasakul; Pithi Chanvorachote
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

7.  Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

Authors:  Hening Ren; Ximing Tang; J Jack Lee; Lei Feng; Allen D Everett; Waun Ki Hong; Fadlo R Khuri; Li Mao
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

8.  Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.

Authors:  Tai-Shan Cheng; Wen-Chi Chen; Ya-Yun Lin; Chin-Hsien Tsai; Chia-I Liao; Hsin-Yi Shyu; Chun-Jung Ko; Sheue-Fen Tzeng; Chun-Yin Huang; Pan-Chyr Yang; Pei-Wen Hsiao; Ming-Shyue Lee
Journal:  Cancer Prev Res (Phila)       Date:  2013-03-06

Review 9.  Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.

Authors:  Garth L Nicolson; Akihiro Nawa; Yasushi Toh; Shigeki Taniguchi; Katsuhiko Nishimori; Amr Moustafa
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells.

Authors:  Xiaoxia Zhu; Xiao Zhang; Haofei Wang; Qingcui Song; Gong Zhang; Lei Yang; Jian Geng; Xiangzhao Li; Yawei Yuan; Longhua Chen
Journal:  Oncol Rep       Date:  2012-04-20       Impact factor: 3.906

View more
  24 in total

1.  Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.

Authors:  Bilal Bin Hafeez; Aditya Ganju; Mohammed Sikander; Vivek K Kashyap; Zubair Bin Hafeez; Neeraj Chauhan; Shabnam Malik; Andrew E Massey; Manish K Tripathi; Fathi T Halaweish; Nadeem Zafar; Man M Singh; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Mol Cancer Ther       Date:  2017-06-14       Impact factor: 6.261

Review 2.  Dietary agents for prevention and treatment of lung cancer.

Authors:  Naghma Khan; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2015-01-30       Impact factor: 8.679

3.  Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells.

Authors:  Jirapat Namkaew; Thiranut Jaroonwitchawan; Narawadee Rujanapun; Jantip Saelee; Parinya Noisa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-22       Impact factor: 2.416

4.  Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis.

Authors:  Youqun Tang; Yanming Cao
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

Review 5.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

6.  MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.

Authors:  Ning Zhou; Haijuan Wang; Hongxu Liu; Hongsheng Xue; Feng Lin; Xiting Meng; Ailing Liang; Zhilong Zhao; YongJun Liu; Haili Qian
Journal:  J Exp Clin Cancer Res       Date:  2015-12-23

7.  Metastasis-Associated Protein 1 Is Involved in Angiogenesis after Transarterial Chemoembolization Treatment.

Authors:  Tao Xue; Wenming Feng; Hongbin Yu; Ming Zhu; Maoyun Fei; Ying Bao; Xiaoyi Wang; Wenxue Ma; Guiyuan Lv; Jianming Guan; Suhong Chen
Journal:  Biomed Res Int       Date:  2017-05-15       Impact factor: 3.411

8.  Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.

Authors:  Bilin Liu; Dan He; Jianyong Wu; Quan Sun; Mi Zhang; Qunyou Tan; Yao Li; Jingqing Zhang
Journal:  Oncotarget       Date:  2017-05-09

9.  Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.

Authors:  De-Min Jiao; Li Yan; Li-Shan Wang; Hui-Zhen Hu; Xia-Li Tang; Jun Chen; Jian Wang; You Li; Qing-Yong Chen
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

Review 10.  Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer.

Authors:  Quhui Wu; Huiping Ou; Yan Shang; Xi Zhang; Junyong Wu; Fuyuan Fan
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.